Coiled coil miniprotein randomization on phage leads to charge pattern mimicry of the receptor recognition determinant of interleukin 5

Phage display was used to identify sequences that mimic structural determinants in interleukin5 (IL5) for IL5 receptor recognition. A coiled coil stem loop (CCSL) miniprotein scaffold library was constructed with its turn region randomized and panned for binding variants against human IL5 receptor α chain (IL5Rα). Competition enzyme‐linked immunosorbent assays identified CCSL‐phage selectants for which binding to IL5Rα was competed by IL5. The most frequently selected and IL5‐competed CCSL‐phage contain charged residues Arg and Glu in their turn sequences, in this regard resembling a β strand sequence in the ‘CD turn’ region, of IL5, that has been proposed to present a key determinant for IL5 receptor α chain recognition. The most dominant CCSL‐phage selectant sequence, PVEGRV, contains a negative/positive charge pattern similar to that seen in the original CD turn. To test the relatedness of CCSL‐phage selectant sequences to the IL5 receptor recognition epitope, PVEGRV was grafted into the sequence 87–92 of a monomeric IL5. The resulting IL5 variant, [87PVEGRV92]GM1, was able to bind to IL5Rα in biosensor assays, to elicit TF‐1 cell proliferation and to induce STAT5 phosphorylation in TF‐1 cells. The results help discern sequence patterns in the IL5 CD turn region which are key in driving receptor recognition and demonstrate the utility of CCSL miniprotein scaffold phage display to identify local IL5 mimetic sequence arrangements that may ultimately lead to IL5 antagonists. Copyright © 2002 John Wiley & Sons, Ltd.

[1]  E. Whitehorn,et al.  A potent dimeric peptide antagonist of interleukin-5 that binds two interleukin-5 receptor alpha chains. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[2]  J. Tavernier,et al.  Detailed analysis of the IL‐5‐IL‐5R alpha interaction: characterization of crucial residues on the ligand and the receptor. , 1995, The EMBO journal.

[3]  I Chaiken,et al.  The coiled coil stem loop miniprotein as a presentation scaffold. , 1996, Drug design and discovery.

[4]  P. O'Byrne,et al.  Allergen-induced increases in IL-5 receptor alpha-subunit expression on bone marrow-derived CD34+ cells from asthmatic subjects. A novel marker of progenitor cell commitment towards eosinophilic differentiation. , 1997, The Journal of clinical investigation.

[5]  M. Lambert,et al.  A novel dimer configuration revealed by the crystal structure at 2.4 Å resolution of human interleukin-5 , 1993, Nature.

[6]  M. Peitsch,et al.  Identification of Key Charged Residues of Human Interleukin-5 in Receptor Binding and Cellular Activation (*) , 1995, The Journal of Biological Chemistry.

[7]  D R Burton,et al.  A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[8]  W. Sewell,et al.  Chronic cough resembles asthma with IL-5 and granulocyte-macrophage colony-stimulating factor gene expression in bronchoalveolar cells. , 1998, The Journal of allergy and clinical immunology.

[9]  M. Doyle,et al.  Monomeric isomers of human interleukin 5 show that 1:1 receptor recruitment is sufficient for function. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[10]  V. Mordvinov,et al.  Biological and molecular characteristics of interleukin-5 and its receptor. , 1998, International reviews of immunology.

[11]  G. Winter,et al.  Selection of phage antibodies by binding affinity. Mimicking affinity maturation. , 1992, Journal of molecular biology.

[12]  M. Sliwkowski,et al.  Binding Interaction of the Heregulinβ egf Domain with ErbB3 and ErbB4 Receptors Assessed by Alanine Scanning Mutagenesis* , 1998, The Journal of Biological Chemistry.

[13]  K. Miyazawa,et al.  Cellular and molecular mechanisms of IL-5 synthesis in atopic diseases: a study with allergen-specific human helper T cells. , 1997, The Journal of allergy and clinical immunology.

[14]  G. Winter,et al.  In vitro assembly of repertoires of antibody chains on the surface of phage by renaturation. , 1994, Journal of molecular biology.

[15]  G. Winter,et al.  Phage antibodies: filamentous phage displaying antibody variable domains , 1990, Nature.

[16]  Rabindra Tambyraja,et al.  Epitope Randomization Redefines the Functional Role of Glutamic Acid 110 in Interleukin-5 Receptor Activation* , 2000, The Journal of Biological Chemistry.

[17]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[18]  J. Scott,et al.  Searching for peptide ligands with an epitope library. , 1990, Science.

[19]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[20]  M. Peitsch,et al.  Spatial Orientation of the α and βc Receptor Chain Binding Sites on Monomeric Human Interleukin-5 Constructs* , 1997, The Journal of Biological Chemistry.

[21]  I. Chaiken,et al.  Construction and Binding Kinetics of a Soluble Granulocyte-Macrophage Colony-stimulating Factor Receptor α-Chain-Fc Fusion Protein* , 1998, The Journal of Biological Chemistry.

[22]  G Canziani,et al.  Randomization of the Receptor α Chain Recruitment Epitope Reveals a Functional Interleukin-5 with Charge Depletion in the CD Loop* , 1999, The Journal of Biological Chemistry.

[23]  I. Chaiken,et al.  Design and characterization of an intramolecular antiparallel coiled coil peptide. , 1994, Biochemistry.

[24]  R. Ames,et al.  Isolation of a neutralizing human RSV antibody from a dominant, non-neutralizing immune repertoire by epitope-blocked panning. , 1996, Journal of immunology.

[25]  P. S. Kim,et al.  Inhibiting HIV-1 Entry Discovery of D-Peptide Inhibitors that Target the gp41 Coiled-Coil Pocket , 1999, Cell.

[26]  S. Durham,et al.  IL‐5 production by allergen‐stimulated T cells following grass pollen immunotherapy for seasonal allergic rhinitis , 1997, Clinical and experimental immunology.

[27]  Ronald W. Barrett,et al.  Small Peptides as Potent Mimetics of the Protein Hormone Erythropoietin , 1996, Science.

[28]  J. Bousquet,et al.  Eosinophilic inflammation in asthma. , 1990, The New England journal of medicine.

[29]  R. Barrett,et al.  Peptides on phage: a vast library of peptides for identifying ligands. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[30]  I. Chaiken,et al.  Multisite mutagenesis of interleukin 5 differentiates sites for receptor recognition and receptor activation. , 2000, Biochemistry.

[31]  I. Chaiken,et al.  Single Chain Human Interleukin 5 and Its Asymmetric Mutagenesis for Mapping Receptor Binding Sites (*) , 1996, The Journal of Biological Chemistry.

[32]  H. Kita,et al.  Bronchial asthma: lessons from murine models. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[33]  H R Hoogenboom,et al.  Natural and designer binding sites made by phage display technology. , 2000, Immunology today.

[34]  C. Sanderson Interleukin-5, Eosinophils, and Disease , 1992 .

[35]  R. Schier,et al.  Efficient in vitro affinity maturation of phage antibodies using BIAcore guided selections. , 1996, Human antibodies and hybridomas.

[36]  J M Thornton,et al.  Small binding proteins selected from a combinatorial repertoire of knottins displayed on phage. , 1998, Journal of molecular biology.

[37]  J. Devlin,et al.  Random peptide libraries: a source of specific protein binding molecules. , 1990, Science.

[38]  J. Tavernier,et al.  A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific α chain and a β chain shared with the receptor for GM-CSF , 1991, Cell.

[39]  M. Migita,et al.  Molecular cloning and expression of the human interleukin 5 receptor , 1992, The Journal of experimental medicine.

[40]  D. Baccanari,et al.  Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine. , 1997, Science.

[41]  R. Cook,et al.  Mutagenesis in the C-terminal region of human interleukin 5 reveals a central patch for receptor alpha chain recognition. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[42]  C. Baecher-Allan,et al.  Recent efforts toward the development of peptide secondary structure mimetics at Molecumetics Ltd. for the discoveries of new drug candidates utilizing combinatorial chemistry with solid phase synthesis are described , 2000 .

[43]  S. Sprang,et al.  Affinity panning of a library of peptides displayed on bacteriophages reveals the binding specificity of BiP , 1993, Cell.